HRPP Policies

DUHS Human Research Protection Program

Policies and Procedures

---

• Advertisement of Research Studies
• Processing Payments to Research Participants 
• Recruitment of Other People's Patients
• Recruitment of Students and Employees
• Review of an Investigator's Request for a Waiver of Selected Inclusion/Exclusion Criteria for a Single Person

Informed Consent

• Consent Monitoring
• Informed Consent and Its Documentation
• IRB Approval Stamp on Consent Forms
• Research Involving Non-English-Speaking Subjects 
• Use of the Legally Authorized Representative in Research
• Use of the Short Form Consent Document
• Waiver of Documentation of Consent 

Conflict of Interest (COI)

• Conflict of Interest Pertaining to DUHS IRB Members and Consultants
• Corrective Actions Declared by the DUSOM Conflict of Interest Committee

Telephone Scripts/Research via Telephone, Mail or e-Mail

• Suggested Format and Content for Telephone Scripts
• Use of Questionnaires by Telephone or Mail

IRB Review

• Allegations of Undue Influence Upon the DUHS IRB
• Amendments to IRB-Approved Studies
• Assessing the Data and Safety Monitoring Plan
• Assessing the Scientific or Scholarly Validity of a Research Protocol
• Assuring Key Personnel Qualifications (Revised Policy Posted on 9-4-2009)
• Case Reports
• Conduct of a Convened IRB Meeting
• Continuing Review
• Declarations of Concordance
• Determining the Frequency of Continuing Review
• Determining Which Studies Need Verification from Sources Other than the Investigator
• Emergency Use
• Expedited Review
• Institutional Oversight of Human Research
• IRB Fees
• IRB Interaction with Compliance Offices
• IRB Membership, Voting and Quorum 
• IRB Minutes
• IRB Processing of Modifications
• Nomination of New IRB Members and Evaluation of Members  
• Quality Improvement (QI) Activities vs. Research
• Research for Which Review by the DUHS HRPP Is Required (includes policy on V.A. research)
• Retention of IRB Records and Research Records
• Review and Approval by Other (Specialty) Committees
• Review and Processing of Problems, Complaints, Concerns, and Questions from Research Subjects
• Role of the Institutional Official (IO)
• Use of Consultants in IRB Review
• Veterans Administration (V.A.) Research Involving Human Subjects

Databases/Repositories & Retrospective Research Including Specimens

• Research Databases and Specimen Repositories
• Research Using Coded Specimens or Coded Private Information
• Use of Existing Data or Specimens in Retrospective Research

Conduct of Research

• Administration of a Study Drug or Study Procedure by a Research Participant's Local Physician (coming soon)
• Autopsy Authorizations
• Blood Drawing for Human Subject Research
• Certificates of Confidentiality
• Compensation and Payment for Research Participation
• Contraceptive Use
• Determining if Research is Subject to or Exempt from the Privacy Rule (HIPAA)
• DUHS Commitment to Uphold Ethical Standards and Practices in Research
• Duke Trainees (Medical Students & Others) Engaged in Research Involving Human Subjects at a Site Other Than Within DUHS
• HIPAA as it Relates to Research
• Injury Compensation for Research Participants
• Investigator Concerns
• Pregnancy Testing (Revised Policy Posted on 5-8-2009)
• Reliance on the IRB of Another Institution, Organization, or an Independent IRB
• Required Education on Protection of Human Subjects
• Research by Faculty or Staff Away From Duke
• Research Involving Multiple Sites
• Research Involving the Use of Thalidomide, Lenalidomide or Analogs Thereof
• Tissue/Specimens that May Be Excluded from Routine Submission to Surgical Pathology (behind the Duke firewall)
• Use of External Sites for Specific Study-Related Activities
• Use of Gadolinium-Based Contrast Agents in Research
• Who May Serve as a Principal Investigator in the DUHS HRPP

Research Involving Drugs, Devices or Biologics

• Humanitarian Use Devices and Their Review
• In Vitro Diagnostic Device Studies - FDA Enforcement Discretion 
• Research Involving Drugs, Biologics or Devices
• Responsibilities of an Investigator Who Is Also a Sponsor
• Significant Risk/Non-Significant Risk Device Determinations by the IRB 
• Use of Pharmacy Investigational Drug Service (IDS)

Vulnerable Populations in Research

• Assessment of Decision Making Capacity in Adult Research Participants
• Determination of Risk in Studies Involving Children
• Research Involving Children
• Research Involving Children Who are Wards of the State
• Research Involving Pregnant Women
• Research Involving Prisoners

Reporting to the IRB

• Prompt Reporting of Unanticipated Problems
• Reporting of Protocol Deviations/Violations

Regulatory Compliance

• Expiration of IRB Approval and Closing Reports
• Holds, Suspensions and Terminations
• Noncompliance Policy
• Reporting IRB Findings to DUHS Officials and Federal Regulatory Agencies 

State Law Considerations

• Mandatory State Reporting Requirements
• State Law as it Relates to Research